Cluster composition

Functions

CategoryNameIntersectionWithQueryPValueGenesInTermGenesInQueryGenesInTermInQueryID
GeneOntologyCellularComponentGolgi cis cisterna

GOLGA8T GOLGA8K

1.32e-0433112GO:0000137
GeneOntologyCellularComponentcis-Golgi network

GOLGA8T GOLGA8K

8.78e-0485112GO:0005801
GeneOntologyCellularComponentGolgi cisterna membrane

GOLGA8T GOLGA8K

1.07e-0394112GO:0032580
GeneOntologyCellularComponentGolgi cisterna

GOLGA8T GOLGA8K

2.19e-03135112GO:0031985
GeneOntologyCellularComponentGolgi stack

GOLGA8T GOLGA8K

3.49e-03171112GO:0005795
Pubmed

Rbx2 regulates neuronal migration through different cullin 5-RING ligase adaptors.

CUL5 GOLGA8K

7.78e-054211224210661
CytobandEnsembl 112 genes in cytogenetic band chr15q13

GOLGA8T GOLGA8K

2.55e-04100112chr15q13
GeneFamilyZinc fingers C2H2-type|ZF class homeoboxes and pseudogenes

SP6 ZNF442

2.90e-027187228
ToppCell367C-Epithelial_cells-Epithelial-B_(AT2)|Epithelial_cells / Donor, Lineage, Cell class and subclass (all cells)

ZNF442 UTP20

2.50e-0497112eab10b1af9cd0ce373cd4d0316e0d7b218630584
ToppCell367C-Epithelial_cells-Epithelial-B_(AT2)-|Epithelial_cells / Donor, Lineage, Cell class and subclass (all cells)

ZNF442 UTP20

2.50e-049711204f571708f2487b0dbd70ee507de6bf75be5f5d9
ToppCellPrimary_Visual_cortex_(V1C)-Neuronal-Inh_GABAergic-i_Gaba_2-GABA_VIP_2-Inh_L3-6_VIP_KCTD13|Primary_Visual_cortex_(V1C) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types

GOLGA8T GOLGA8K

6.03e-041511121fd43cda3ac4d1c96560338fcfb6c346b1dec0a2
ToppCellPND07-Endothelial-Endothelial_blood-vessel-Microvascular_EC-EPC-EPC_mature|PND07 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif

MTMR3 CHST15

6.44e-041561121928c86deb3bcd01db4ae76919a351066aadb39a
ToppCellrenal_cortex_nuclei-Hypertensive_with+without-CKD-Mesenchymal-Fibroblast-Collagen-high_Fibroblast-|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group

ALKBH4 CHST15

6.68e-04159112cbb331eb689d8cea9e1146ba85e0a05d23301c47
ToppCellrenal_cortex_nuclei-Hypertensive_with+without-CKD-Mesenchymal-Fibroblast-Collagen-high_Fibroblast|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group

ALKBH4 CHST15

6.68e-04159112330ecbba97d47bc818a5e8d1d84b05d056bd831e
ToppCelldroplet-Large_Intestine-COLON_PROXIMAL-30m-Epithelial-Lgr5+_amplifying_undifferentiated_cell|Large_Intestine / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation

CUL5 UTP20

7.46e-04168112d69452e2cfeb74023b5cf3d09064d7dcad0008ec
ToppCellfacs-Brain_Non-Myeloid-Striatum-24m-Neuronal-medium_spiny_neuron|Brain_Non-Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation

ABCC8 CHST15

7.46e-04168112b96a48552f4236a95bbcdce2f1b05041086d7101
ToppCellfacs-Brain_Non-Myeloid-Striatum-24m-Neuronal-SPN_Neuron_STR|Brain_Non-Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation

ABCC8 CHST15

7.46e-04168112b87fc63f9e35dfcfc46cb129ea569e73c5e018bb
ToppCelldroplet-Lung-nan-3m-Lymphocytic-Regulatory_T|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation

SP6 ABCC8

7.46e-041681121df3c8c7a6dceb901805eaba7f86f9943f4f1a9d
ToppCelldroplet-Lung-nan-3m-Lymphocytic-regulatory_T_cell|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation

SP6 ABCC8

7.46e-041681121586451d437b70b2dffe41d782b694702dcaf50b
ToppCellPrimary_Motor_Cortex_(M1)-Neuronal-Glutamatergic_Excit-Glut_C-D_(RORB)-Glut_D_(IT_RORB_THEMIS_LINC00507)_3-Exc_L3_THEMIS_PLA2G7|Primary_Motor_Cortex_(M1) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types

GOLGA8T GOLGA8K

7.81e-041721121d086e00cd549459d70e1d3b468d5ab6379f3bee
ToppCellChildren_(3_yrs)-Immune-enucleated_erythrocyte|Children_(3_yrs) / Lineage, Cell type, age group and donor

ABCC8 ZNF442

8.09e-0417511236cb3c8116bd467ee5da0630d8b3d3e4afcc2ded
ToppCellAdult-Endothelial-capillary_endothelial_cell_(Cap1)-D175|Adult / Lineage, Cell type, age group and donor

SP6 ABCC8

9.22e-04187112f3548817f2fded5978137bb252cb628ac199e4f6
ToppCelldroplet-Large_Intestine-COLON_PROXIMAL-30m-Epithelial-Lgr5-_amplifying_undifferentiated_cell|Large_Intestine / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation

CUL5 UTP20

9.52e-0419011236e83995021ba16690f84e2077a9e8baec547d05
ToppCelldroplet-Large_Intestine-COLON_PROXIMAL-30m-Epithelial-epithelial_cell_of_large_intestine|Large_Intestine / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation

CUL5 UTP20

9.52e-04190112d26be9e1b676f750e716b91ebc3598fac3735612
ToppCellCOPD-Endothelial-VE_Capillary_B|COPD / Disease state, Lineage and Cell class

SP6 ABCC8

9.92e-0419411218b7f901c12ca4f21f9a1eafd092aefe4d668b6d
ToppCellCOPD-Endothelial-VE_Capillary_B|World / Disease state, Lineage and Cell class

SP6 ABCC8

9.92e-0419411268705a6eca947c5b42b943d5224a7aef2a744007
ToppCellLung_Parenchyma-Control-Endothelial-Endothelial-Capillary|Control / Location, Disease Group, Cell group, Cell class (2021.03.09)

SP6 ABCC8

1.04e-031991123fea92affacd4c1f588fa81807df35d6c69b7241
ToppCellLung_Parenchyma-Control-Endothelial-Endothelial-Capillary-|Control / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01)

SP6 ABCC8

1.04e-03199112993999adf346b4fd557989bc53c17eb0ccb996c9
ToppCellParenchyma_Control_(B.)-Endothelial-TX-Capillary|Parenchyma_Control_(B.) / Sample group, Lineage and Cell type

SP6 ABCC8

1.04e-0319911289f4db619fbed90f7fdf6ece7a671e514b5c6d76
ToppCell(04)_Interm._basal>secr.-(2)_GFP_FOXI1|(04)_Interm._basal>secr. / shred by cell type by condition

NSRP1 CHST15

1.04e-0319911253ca3861f9e00dab3f3fbefb0837857ee39ab084
ToppCellNeuronal-Inhibitory-iA-iA_3(VIP)-VIP_3-QPCT-L2-6|Neuronal / cells hierarchy compared to all cells using T-Statistic

GOLGA8T GOLGA8K

1.05e-032001122f2c5331511a924fa0bb1689f4c81641d754c9b9
ToppCellNeuronal-Inhibitory-iA-iA_3(VIP)-VIP_3-QPCT|Neuronal / cells hierarchy compared to all cells using T-Statistic

GOLGA8T GOLGA8K

1.05e-0320011285e1b598c9f3976215b20eeda077d8aab621cce6
DrugFlufenamic acid [530-78-9]; Up 200; 14.2uM; HL60; HG-U133A

ALKBH4 MTMR3 CUL5

5.24e-05198931420_UP
DrugAntipyrine [60-80-0]; Down 200; 21.2uM; MCF7; HT_HG-U133A

ALKBH4 MTMR3 ZNF442

5.31e-05199931489_DN
DrugBeta-Escin [11072-93-8]; Up 200; 3.2uM; PC3; HT_HG-U133A

MTMR3 CUL5

2.02e-03174924544_UP
DrugTrichostatin A, from Streptomyces sp.; Down 200; 0.1uM; MCF7; HT_HG-U133A

ALKBH4 CUL5

2.06e-03176922639_DN
Drugtrichostatin A, Streptomyces sp.; Down 200; 1uM; MCF7; HT_HG-U133A

CUL5 CHST15

2.06e-03176927499_DN
Drugfelodipine; Up 200; 10uM; MCF7; HT_HG-U133A_EA

MTMR3 ZNF442

2.20e-0318292848_UP
Drug17-AAG; Up 200; 1uM; PC3; HT_HG-U133A

CUL5 ZNF442

2.28e-03185921226_UP
DrugAG-1478; Down 200; 31.6uM; MCF7; HT_HG-U133A_EA

CUL5 UTP20

2.33e-03187921141_DN
Drug2-propylpentanoic acid; Down 200; 10000uM; MCF7; HG-U133A

ALKBH4 CUL5

2.35e-0318892345_DN
DrugRapamycin; Down 200; 0.1uM; MCF7; HT_HG-U133A_EA

CUL5 UTP20

2.37e-03189921045_DN
DrugSecurinine [5610-40-2]; Down 200; 18.4uM; PC3; HT_HG-U133A

ALKBH4 ZNF442

2.40e-03190924493_DN
DrugDienestrol [84-17-3]; Up 200; 15uM; MCF7; HT_HG-U133A

MTMR3 ZNF442

2.42e-03191923448_UP
DrugPronethalol hydrochloride [51-02-5]; Down 200; 15uM; MCF7; HT_HG-U133A

CUL5 UTP20

2.45e-03192924104_DN
DrugTrichostatin A, from Streptomyces sp.; Down 200; 0.1uM; HL60; HT_HG-U133A

CUL5 UTP20

2.47e-03193922370_DN
DrugFluphenazine dihydrochloride [146-56-5]; Up 200; 7.8uM; HL60; HG-U133A

MTMR3 CUL5

2.47e-03193921577_UP
DrugTerazosin hydrochloride [63590-64-7]; Up 200; 9.4uM; MCF7; HT_HG-U133A

MTMR3 CUL5

2.47e-03193927187_UP
DrugPyrithyldione [77-04-3]; Down 200; 24uM; PC3; HT_HG-U133A

MTMR3 CUL5

2.47e-03193927153_DN
DrugNifuroxazide [965-52-6]; Up 200; 14.6uM; MCF7; HT_HG-U133A

MTMR3 ZNF442

2.47e-03193924835_UP
DrugNSC23615

ABCC8 CUL5

2.47e-0319392CID000000640
DrugC768-0445; Down 200; 10uM; MCF7; HT_HG-U133A_EA

ALKBH4 UTP20

2.47e-0319392865_DN
DrugIdoxuridine [54-42-2]; Down 200; 11.2uM; MCF7; HT_HG-U133A

ALKBH4 ZNF442

2.50e-03194921480_DN
DrugLactobionic acid [96-82-2]; Down 200; 11.2uM; MCF7; HT_HG-U133A

ALKBH4 ZNF442

2.50e-03194924950_DN
DrugBenzethonium chloride [121-54-0]; Down 200; 9uM; MCF7; HT_HG-U133A

ALKBH4 MTMR3

2.50e-03194926070_DN
DrugRapamycin; Down 200; 0.1uM; MCF7; HT_HG-U133A

ALKBH4 UTP20

2.50e-03194926958_DN
DrugOxolinic acid [14698-29-4]; Up 200; 15.4uM; HL60; HG-U133A

MTMR3 CUL5

2.53e-03195921419_UP
DrugPerhexiline maleate [6724-53-4]; Down 200; 10.2uM; MCF7; HT_HG-U133A

ALKBH4 UTP20

2.53e-03195927441_DN
DrugDiperodon hydrochloride [537-12-2]; Up 200; 9.2uM; HL60; HG-U133A

MTMR3 CUL5

2.53e-03195921575_UP
DrugButylparaben [94-26-8]; Down 200; 20.6uM; MCF7; HT_HG-U133A

CUL5 UTP20

2.53e-03195925245_DN
Drugestradiol, USP; Up 200; 0.01uM; MCF7; HT_HG-U133A

ALKBH4 ZNF442

2.55e-03196921666_UP
DrugCarisoprodol [78-44-4]; Down 200; 15.4uM; PC3; HT_HG-U133A

ALKBH4 ZNF442

2.55e-03196926610_DN
DrugCefoperazone dihydrate; Down 200; 5.8uM; PC3; HT_HG-U133A

ALKBH4 ZNF442

2.55e-03196926323_DN
DrugFlavoxate hydrochloride [3717-88-2]; Down 200; 9.4uM; HL60; HT_HG-U133A

ALKBH4 CUL5

2.55e-03196922373_DN
DrugCrotamiton [483-63-6]; Down 200; 19.6uM; PC3; HT_HG-U133A

ALKBH4 ZNF442

2.55e-03196924628_DN
DrugMeclofenamic acid sodium salt monohydrate [6385-02-0]; Up 200; 11.8uM; HL60; HG-U133A

ALKBH4 CUL5

2.55e-03196921445_UP
DrugPivampicillin [33817-20-8]; Down 200; 8.6uM; MCF7; HT_HG-U133A

MTMR3 ZNF442

2.55e-03196925465_DN
DrugThiamphenicol [15318-45-3]; Up 200; 11.2uM; HL60; HT_HG-U133A

MTMR3 CUL5

2.55e-03196921867_UP
Drugalpha-estradiol; Up 200; 0.01uM; HL60; HT_HG-U133A

MTMR3 CHST15

2.55e-03196926169_UP
DrugChrysene-1,4-quinone [100900-16-1]; Down 200; 15.4uM; PC3; HT_HG-U133A

MTMR3 CUL5

2.55e-03196927139_DN
DrugTerconazole [67915-31-5]; Down 200; 7.6uM; MCF7; HT_HG-U133A

ALKBH4 ZNF442

2.55e-03196924407_DN
DrugGuanabenz acetate [23256-50-0]; Up 200; 13.8uM; PC3; HG-U133A

MTMR3 CHST15

2.55e-03196921961_UP
Drugrosiglitazone; Up 200; 10uM; MCF7; HT_HG-U133A_EA

MTMR3 CUL5

2.58e-03197921013_UP
DrugMethyldopa (L,-) [555-30-6]; Up 200; 19uM; MCF7; HT_HG-U133A

ABCC8 ZNF442

2.58e-03197925637_UP
DrugPhenindione [83-12-5]; Down 200; 18uM; MCF7; HT_HG-U133A

ALKBH4 ZNF442

2.58e-03197922868_DN
DrugApramycin [37321-09-8]; Up 200; 7.4uM; MCF7; HT_HG-U133A

MTMR3 ZNF442

2.58e-03197927334_UP
DrugChlorpropamide [94-20-2]; Down 200; 14.4uM; PC3; HT_HG-U133A

MTMR3 ZNF442

2.58e-03197926291_DN
DrugAtropine sulfate monohydrate [5908-99-6]; Up 200; 5.8uM; MCF7; HT_HG-U133A

MTMR3 ZNF442

2.58e-03197922761_UP
DrugPiperacetazine [3819-00-9]; Up 200; 9.8uM; HL60; HT_HG-U133A

MTMR3 ZNF442

2.58e-03197926152_UP
DrugMianserine hydrochloride [21535-47-7]; Up 200; 13.2uM; HL60; HG-U133A

ALKBH4 CUL5

2.58e-03197921385_UP
DrugTrioxsalen [3902-71-4]; Down 200; 17.6uM; MCF7; HT_HG-U133A

MTMR3 CUL5

2.58e-03197926078_DN
DrugBaclofen (R,S) [1134-47-0]; Down 200; 18.8uM; PC3; HT_HG-U133A

ALKBH4 ZNF442

2.58e-03197926313_DN
Drugtrifluoperazine dihydrochloride; Down 200; 10uM; MCF7; HT_HG-U133A

ALKBH4 UTP20

2.58e-03197926984_DN
DrugFlucloxacillin sodium [1847-24-1]; Down 200; 8.4uM; MCF7; HT_HG-U133A

ALKBH4 CUL5

2.58e-03197925527_DN
DrugSeneciphylline [480-81-9]; Up 200; 12uM; HL60; HT_HG-U133A

CUL5 ZNF442

2.58e-03197922140_UP
DrugPenbutolol sulfate [38363-32-5]; Up 200; 5.8uM; MCF7; HT_HG-U133A

MTMR3 ZNF442

2.58e-03197927476_UP
DrugBenperidol [2062-84-2]; Up 200; 10.4uM; MCF7; HT_HG-U133A

ALKBH4 ABCC8

2.58e-03197922836_UP
Diseasehemoglobin A1 measurement

SP6 MTMR3 ABCC8

4.22e-0452093EFO_0007629
DiseaseDrugs used in diabetes use measurement

SP6 ABCC8

2.57e-0325592EFO_0009924
Diseasereticulocyte measurement

SP6 MTMR3 CUL5

3.24e-03105393EFO_0010700
DiseaseMalignant neoplasm of breast

MTMR3 CUL5 UTP20

3.43e-03107493C0006142
DiseaseS-6-hydroxywarfarin measurement

CHST15 UTP20

5.27e-0336892EFO_0803326
DiseaseHbA1c measurement

SP6 ABCC8

1.69e-0267592EFO_0004541
Diseasechronic obstructive pulmonary disease

NSRP1 MTMR3

1.75e-0268892EFO_0000341

Protein segments in the cluster

PeptideGeneStartEntry
GAARHQWKHAIHRRH

ALKBH4

246

Q9NXW9
HSGRKLHWHHLMSNG

CUL5

566

Q93034
HREASHRDSHWKRHE

NSRP1

346

Q9H0G5
HHWRDRRHQKTHHLL

GOLGA8T

481

H3BQL2
HWRDRRHQKTHHLLS

GOLGA8K

481

D6RF30
SAHLHSRNLHHKWLH

MTMR3

981

Q13615
SRNLHHKWLHSHSGR

MTMR3

986

Q13615
LSKIWSHVHSHLRHP

UTP20

2461

O75691
AKTSHLKAHLRWHSG

SP6

266

Q3SY56
HHSTWLHFPGHNLRW

ABCC8

61

Q09428
FWGHLAHAHGKHFRL

CHST15

236

Q7LFX5
SLSSLHRHKRTHWRD

ZNF442

611

Q9H7R0